Thalidomide 4'-oxyacetamide-alkylC4-azide

Pricing Availability   Qty
Cat.No. 6300 - Thalidomide 4'-oxyacetamide-alkylC4-azide | C19H20N6O6 | CAS No. 2098488-36-7
Description: Cereblon ligand with alkyl linker and terminal azide for onward chemistry
Alternative Names: Azido-Thalidomide
Chemical Name: N-(4-Azidobutyl)-2-[[2-(2,6-dioxo-3-piperidinyl)-2,3-dihydro-1,3-dioxo-1H-isoindol-4-yl]oxy]acetamide
Purity: ≥98% (HPLC)
Datasheet
Citations
Reviews
Literature (2)

Biological Activity

Click-activated Thalidomide (Cat.No. 0652); precursor to PROTAC® that hijacks cereblon as the E3 ubiquitin ligase component. Supplied with an azide functional handle at a position known not to significantly affect binding to cereblon, for ready click conjugation to a linker/target protein ligand.

This product has been recently renamed. The previous name for this product was Azido-Thalidomide

PROTAC® is a registered trademark of Arvinas Operations, Inc., and is used under license

Usage Guidelines

This product is provided for use in onward chemistry. Suitable solvents can be used.

Technical Data

M. Wt 428.4
Formula C19H20N6O6
Storage Store at -20°C
Purity ≥98% (HPLC)
CAS Number 2098488-36-7
PubChem ID 131704500
InChI Key USWFAZSQVLTHHA-UHFFFAOYSA-N
Smiles [N-]=[N+]=NCCCCNC(COC1=C2C(N(C(C2=CC=C1)=O)C3CCC(NC3=O)=O)=O)=O

The technical data provided above is for guidance only. For batch specific data refer to the Certificate of Analysis.

Tocris products are intended for laboratory research use only, unless stated otherwise.

References

References are publications that support the biological activity of the product.

Schiedel et al (2018) Chemically induced degradation of sirtuin 2 (Sirt2) by a proteolysis targeting chimera (PROTAC) based on sirtuin rearranging ligands (SirReals). J.Med.Chem. 61 482 PMID: 28379698


If you know of a relevant reference for Thalidomide 4'-oxyacetamide-alkylC4-azide, please let us know.

Keywords: Thalidomide 4'-oxyacetamide-alkylC4-azide, Thalidomide 4'-oxyacetamide-alkylC4-azide supplier, PROTACs, click-activated, thalidomide, E3, ligase, ligands, cereblon, Azido-Thalidomide, Cereblon, Ligands, Plus, Linkers, 6300, Tocris Bioscience

Citations for Thalidomide 4'-oxyacetamide-alkylC4-azide

Citations are publications that use Tocris products.

Currently there are no citations for Thalidomide 4'-oxyacetamide-alkylC4-azide. Do you know of a great paper that uses Thalidomide 4'-oxyacetamide-alkylC4-azide from Tocris? Please let us know.

Reviews for Thalidomide 4'-oxyacetamide-alkylC4-azide

There are currently no reviews for this product. Be the first to review Thalidomide 4'-oxyacetamide-alkylC4-azide and earn rewards!

Have you used Thalidomide 4'-oxyacetamide-alkylC4-azide?

Submit a review and receive an Amazon gift card.

$50/€35/£30/$50CAN/¥300 Yuan/¥5000 Yen for first to review with an image

$25/€18/£15/$25CAN/¥75 Yuan/¥1250 Yen for a review with an image

$10/€7/£6/$10 CAD/¥70 Yuan/¥1110 Yen for a review without an image

Submit a Review

Literature in this Area

Tocris offers the following scientific literature in this area to showcase our products. We invite you to request* your copy today!

*Please note that Tocris will only send literature to established scientific business / institute addresses.


Targeted Protein Degradation

Targeted Protein Degradation Research Product Guide

This brochure highlights the tools and services available from Bio-Techne to support Targeted Protein Degradation research, including:

  • Active Degraders
  • Degrader Building Blocks
  • Custom Degrader Services
  • UPS Proteins and Assays
  • Assays for Protein Degradation
Targeted Protein Degradation

Targeted Protein Degradation Poster

Degraders (e.g. PROTACs) are bifunctional small molecules, that harness the Ubiquitin Proteasome System (UPS) to selectively degrade target proteins within cells. They consist of three covalently linked components: an E3 ubiquitin ligase ligand, a linker and a ligand for the target protein of interest. Authored in-house, this poster outlines the generation of a toolbox of building blocks for the development of Degraders. The characteristics and selection of each of these components are discussed. Presented at EFMC 2018, Ljubljana, Slovenia